Toxic shock syndrome

Reading File
Finding Sources
Searching Images

toxic shock syndrome rash clinical presentation

This composite clinical photograph displays the dermatological and musculoskeletal presentation of a pediatric patient with systemic illness, likely Toxic Shock Syndrome secondary to Group A Streptococcus infection. Panel A shows the abdomen/trunk with a diffuse, erythematous macular rash consisting of non-elevated, blanching red spots. Panel B illustrates similar macular findings on the dorsal surface of the foot and lower leg. Panel C provides two views (dorsal and volar) of the left upper extremity, demonstrating significant localized edema (swelling) of the forearm, wrist, and hand. The skin of the forearm appears erythematous and tense, though no overt skin breaks or cellulitis are visible at the time of presentation. This combination of findings—a diffuse scarlatiniform-like rash and localized extremity swelling—is clinically significant for identifying early signs of invasive soft tissue infection and systemic inflammatory response.

This composite clinical photograph displays the dermatological and musculoskeletal presentation of a pediatric patient with systemic illness, likely Toxic Shock Syndrome secondary to Group A Streptococcus infection. Panel A shows the abdomen/trunk with a diffuse, erythematous macular rash consisting of non-elevated, blanching red spots. Panel B illustrates similar macular findings on the dorsal surface of the foot and lower leg. Panel C provides two views (dorsal and volar) of the left upper extremity, demonstrating significant localized edema (swelling) of the forearm, wrist, and hand. The skin of the forearm appears erythematous and tense, though no overt skin breaks or cellulitis are visible at the time of presentation. This combination of findings—a diffuse scarlatiniform-like rash and localized extremity swelling—is clinically significant for identifying early signs of invasive soft tissue infection and systemic inflammatory response.

Clinical photograph of a 54-year-old female patient's anterior torso demonstrating a diffuse, erythematous macular rash on the chest and abdomen. The skin exhibits confluent redness, characteristic of a systemic inflammatory or toxic response. Anatomically, the left breast region shows evidence of recent surgery (mastectomy/reconstruction) with a visible surgical incision and suture lines. On the right and left infraclavicular regions, central venous access devices or monitoring lines are present, secured with adhesive dressings. Notably, the right-sided insertion site shows peri-catheter reddish-brown staining. Multiple small, benign-appearing pigmented nevi are scattered across the trunk. This visual presentation, in the context of postoperative fever and hypotension, is clinically representative of Toxic Shock Syndrome (TSS) following breast surgery and tissue expander placement. The image serves as an educational example of early-onset postoperative TSS manifestations, emphasizing the appearance of the classic diffuse scarlatiniform eruption.

Clinical photograph of a 54-year-old female patient's anterior torso demonstrating a diffuse, erythematous macular rash on the chest and abdomen. The skin exhibits confluent redness, characteristic of a systemic inflammatory or toxic response. Anatomically, the left breast region shows evidence of recent surgery (mastectomy/reconstruction) with a visible surgical incision and suture lines. On the right and left infraclavicular regions, central venous access devices or monitoring lines are present, secured with adhesive dressings. Notably, the right-sided insertion site shows peri-catheter reddish-brown staining. Multiple small, benign-appearing pigmented nevi are scattered across the trunk. This visual presentation, in the context of postoperative fever and hypotension, is clinically representative of Toxic Shock Syndrome (TSS) following breast surgery and tissue expander placement. The image serves as an educational example of early-onset postoperative TSS manifestations, emphasizing the appearance of the classic diffuse scarlatiniform eruption.

This clinical photograph shows the facial and upper chest region of a pediatric patient presenting with an extensive, symmetrically distributed dermatological eruption. The primary visual findings include a confluent, erythematous, and macular rash with an edematous appearance. The distribution is prominently periorbital (involving the infraorbital and malar areas) and perioral, with extension onto the cheeks and chin. Scattered erythematous macules are also visible on the forehead. The rash continues inferiorly onto the neck and upper chest, where it appears more diffuse and confluent. The skin in the affected areas shows signs of mild swelling without evident deep ulceration or mucosal involvement in the visible oral cavity. This clinical presentation is characteristic of systemic inflammatory or infectious processes such as Staphylococcal Scalded Skin Syndrome (SSSS), early Stevens-Johnson Syndrome (SJS), or toxic shock syndrome, where characteristic periorificial accentuation and superficial skin desquamation are common educational hallmarks.

This clinical photograph shows the facial and upper chest region of a pediatric patient presenting with an extensive, symmetrically distributed dermatological eruption. The primary visual findings include a confluent, erythematous, and macular rash with an edematous appearance. The distribution is prominently periorbital (involving the infraorbital and malar areas) and perioral, with extension onto the cheeks and chin. Scattered erythematous macules are also visible on the forehead. The rash continues inferiorly onto the neck and upper chest, where it appears more diffuse and confluent. The skin in the affected areas shows signs of mild swelling without evident deep ulceration or mucosal involvement in the visible oral cavity. This clinical presentation is characteristic of systemic inflammatory or infectious processes such as Staphylococcal Scalded Skin Syndrome (SSSS), early Stevens-Johnson Syndrome (SJS), or toxic shock syndrome, where characteristic periorificial accentuation and superficial skin desquamation are common educational hallmarks.

Clinical photograph of a patient's torso in a critical care setting, demonstrating an exuberant, diffuse erythematous rash. The skin exhibits a widespread, uniform reddish discoloration across the chest and abdomen. A notable feature is the blanching nature of the erythema, where the redness temporarily disappears under digital pressure, as demonstrated by the presence of a gloved hand and lighter patches in the lower left abdominal region. The rash appears macular and confluent without obvious vesicles, papules, or petechiae. Medical monitoring equipment, including ECG leads and tubing, is visible on the patient, indicating an acute clinical presentation. This visual manifestation is associated with streptococcal shock or toxic shock syndrome (TSS), representing a systemic inflammatory response. The image is used to teach medical students and residents about the dermatologic signs of sepsis and the physical examination technique of blanching in capillary-refill assessment.

Clinical photograph of a patient's torso in a critical care setting, demonstrating an exuberant, diffuse erythematous rash. The skin exhibits a widespread, uniform reddish discoloration across the chest and abdomen. A notable feature is the blanching nature of the erythema, where the redness temporarily disappears under digital pressure, as demonstrated by the presence of a gloved hand and lighter patches in the lower left abdominal region. The rash appears macular and confluent without obvious vesicles, papules, or petechiae. Medical monitoring equipment, including ECG leads and tubing, is visible on the patient, indicating an acute clinical presentation. This visual manifestation is associated with streptococcal shock or toxic shock syndrome (TSS), representing a systemic inflammatory response. The image is used to teach medical students and residents about the dermatologic signs of sepsis and the physical examination technique of blanching in capillary-refill assessment.

Searching PubMed

"toxic shock syndrome"[MeSH Terms] AND management

Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
I now have comprehensive content. Let me compile the full answer.

Toxic Shock Syndrome (TSS)

Definition and Overview

Toxic shock syndrome is a toxin-mediated systemic inflammatory response characterized by rapid-onset high fever, hypotension, diffuse erythroderma with subsequent desquamation, and multiorgan dysfunction. It was first described in 1978 in seven children and gained major public attention in the early 1980s when it was linked to superabsorbent tampon use in young menstruating women.
  • Rosen's Emergency Medicine, p. 2603
  • Dermatology 2-Volume Set 5e, p. 1522

Etiology

There are two main forms:
FeatureStaphylococcal TSSStreptococcal TSS
OrganismStaphylococcus aureusGroup A Streptococcus pyogenes
Typical patientYoung (15-35 yrs), healthyYoung (20-50 yrs), healthy
Diffuse erythrodermaVery commonLess common
Soft tissue infectionRareCommon (necrotizing fasciitis)
Blood culture positive<15%>50%
Mortality<3%30-60%
Key predisposing factorsTampon, surgical packing, abscessLacerations, bites, bruises, varicella
Streptococcal TSS currently accounts for approximately two-thirds of all TSS cases (as of CDC data 2010-2015).

Pathophysiology

Staphylococcal TSS: Caused by colonization or infection with toxigenic S. aureus strains that produce Toxic Shock Syndrome Toxin-1 (TSST-1). TSST-1 is identified in >90% of menstrual cases and ~60% of nonmenstrual cases. S. aureus also produces enterotoxin B. Because the organism is often non-invasive, blood cultures are frequently negative.
Streptococcal TSS: Caused by invasive infection with toxigenic group A streptococcus, producing streptococcal pyrogenic exotoxins A and B (SPE-A, SPE-B).
Common mechanism - Superantigen activation: Both TSST-1 and streptococcal pyrogenic exotoxins act as superantigens. Rather than being processed through normal antigen presentation:
  • They bind directly to MHC class II molecules on antigen-presenting cells AND to the V-beta region of T-cell receptors
  • This activates up to 20-30% of all T cells simultaneously (vs. <0.01% in a normal immune response)
  • Massive release of cytokines: TNF-alpha, interleukins (IL-1, IL-2, IL-6)
  • This cytokine storm drives systemic vasculitis, capillary leak, hypotension, and multisystem organ failure
Antibodies against these toxins are protective. Host immune factors significantly influence disease susceptibility.
  • Rosen's Emergency Medicine, p. 2603-2604

Risk Factors

  • Use of superabsorbent tampons
  • Postoperative wound infections / nasal packing / surgical mesh
  • Postpartum period
  • Burns, dialysis catheters
  • Common bacterial infections
  • Influenza A or varicella infection
  • Diabetes mellitus, HIV, chronic cardiac/pulmonary disease
  • Ethanol abuse
  • Cancer
  • NSAID use (may mask symptoms rather than directly predispose)

Clinical Features

Prodrome: Fatigue, localized pain, and nonspecific symptoms (myalgias, headache, nausea, diarrhea).
Rapid progression to:
1. Fever - Temperature >38.9°C (>102°F), often abrupt onset
2. Rash - Diffuse, blanching, macular erythroderma (sunburn-like). Starts on the trunk and spreads to the extremities. Erythema and edema of palms, soles, and oral mucosa. Conjunctival hyperemia.
3. Desquamation - Full-thickness skin peeling, most prominently of the hands and feet, occurring 1-3 weeks after onset. After recovery, Beau's lines and nail shedding can occur.
4. Hypotension - Systolic BP <90 mmHg in adults (septic shock physiology)
5. Mucous membrane involvement - "Strawberry tongue," pharyngitis, vaginitis, conjunctivitis (non-exudative)
6. Multiorgan dysfunction - GI (vomiting, diarrhea), renal failure, hepatic dysfunction, altered consciousness, DIC, ARDS
Streptococcal TSS additionally features localized extremity pain and frank soft tissue infection (necrotizing fasciitis, myositis).
TSS - diffuse erythematous macular rash (trunk and foot) in pediatric patient with group A streptococcal TSS
Diffuse scarlatiniform eruption in TSS following breast surgery - blanching erythema on trunk

Diagnostic Criteria

Staphylococcal TSS (CDC Case Definition - Revised)

All 5 must be present for CONFIRMED case (4 of 5 = PROBABLE):
  1. Fever: Temperature >38.9°C
  2. Rash: Diffuse macular erythroderma
  3. Desquamation: 1-2 weeks after onset, especially palms and soles
  4. Hypotension: Systolic BP <90 mmHg (adults) or <5th percentile for age (children <16 yr)
  5. Multisystem involvement - 3 or more of:
    • GI: Vomiting or diarrhea at onset
    • Muscular: Severe myalgia or CK ≥2x upper limit of normal
    • Mucous membranes: Vaginal, oropharyngeal, or conjunctival hyperemia
    • Renal: BUN or creatinine ≥2x ULN or pyuria without UTI
    • Hepatic: Bilirubin, AST, ALT ≥2x ULN
    • Hematologic: Platelets <100,000/mm³
    • CNS: Disorientation or altered consciousness without focal neurologic signs (when fever and hypotension absent)
  6. Negative cultures for other causes (blood, throat, CSF); negative serology for RMSF, leptospirosis, measles

Streptococcal TSS (CDC Case Definition)

  • Isolation of group A streptococcus from a sterile site (DEFINITE) or non-sterile site (PROBABLE)
  • PLUS Hypotension (SBP ≤90 mmHg)
  • PLUS 2 or more of: renal impairment, coagulopathy/DIC, liver impairment, ARDS, generalized erythematous rash ± desquamation, soft tissue necrosis (necrotizing fasciitis, myositis, gangrene)

Differential Diagnosis

TSS must be distinguished from:
  • Kawasaki disease (especially in children)
  • Scarlet fever
  • Staphylococcal scalded skin syndrome (SSSS)
  • Early toxic epidermal necrolysis (TEN)
  • Rocky Mountain spotted fever
  • Leptospirosis
  • Meningococcemia

Treatment

1. Aggressive Resuscitation

  • IV fluid replacement - large volumes for septic shock physiology
  • Vasopressors (norepinephrine first-line) for refractory hypotension
  • Ventilatory support as needed (ARDS is common)

2. Source Control

  • Remove the focus immediately: tampon, nasal packing, surgical mesh, barrier contraceptives
  • Drain abscesses; surgical debridement for necrotizing fasciitis (streptococcal TSS)

3. Antibiotics (empirical, cover both Staph and Strep including MRSA)

  • Clindamycin - preferred adjunct because it suppresses toxin/protein synthesis (anti-ribosomal), reducing ongoing cytokine drive
  • Vancomycin - for MRSA coverage
  • Linezolid - alternative; also suppresses protein synthesis
  • Beta-lactamase-resistant penicillins (nafcillin) or first-generation cephalosporins for MSSA
  • Broad-spectrum options: piperacillin-tazobactam, imipenem/meropenem
Key principle: Combine a protein-synthesis-inhibiting antibiotic (clindamycin or linezolid) with a cell-wall agent (vancomycin/beta-lactam) to both kill the organism AND stop toxin production.

4. Adjuncts

  • IV Immunoglobulin (IVIg) - neutralizes circulating superantigen toxins; used in severe/refractory cases
  • Low-dose corticosteroids - considered in severe shock unresponsive to antibiotics and vasopressors

Prognosis and Complications

With appropriate treatment, most patients fully recover. However, complications include:
  • Decreased renal function
  • Prolonged weakness and fatigue
  • Protracted myalgias
  • Vocal cord paralysis, upper extremity paresthesias
  • Carpal tunnel syndrome
  • Arthralgias
  • Amenorrhea
  • Gangrene (in streptococcal TSS)
  • Telogen effluvium (hair loss) in severe cases
Mortality: Staphylococcal TSS now <3% (was 10% in 1980). Streptococcal TSS remains 30-70%.

Sources: Rosen's Emergency Medicine (9e), p. 2601-2607; Dermatology 2-Volume Set 5e, p. 1521-1523; Goldman-Cecil Medicine
This is a shared conversation. Sign in to Orris to start your own chat.